|
|
|
Insider
Information: |
Lambert Nicole |
Relationship: |
Director |
City: |
Salt Lake City |
State: |
UT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
247,993 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,244,696 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
247,993 |
|
|
Total
Value |
$6,244,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Myriad Genetics Inc |
MYGN |
Chief Operating Officer |
2023-10-09 |
223,993 |
2019-09-25 |
0 |
Premium* |
|
Arcus Biosciences Inc |
RCUS |
Director |
2024-06-06 |
24,000 |
2021-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RCUS |
Arcus Biosciences Inc |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,400 |
24,000 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
See Remarks |
|
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
174,486 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
See Remarks |
|
2021-09-27 |
4 |
AS |
$33.10 |
$334,747 |
D/D |
(10,112) |
178,072 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
|
2023-10-09 |
4 |
D |
$15.01 |
$181,786 |
D/D |
(12,111) |
223,993 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
|
2022-10-09 |
4 |
D |
$19.62 |
$237,755 |
D/D |
(12,118) |
229,257 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
See Remarks |
|
2021-10-09 |
4 |
D |
$30.88 |
$385,475 |
D/D |
(12,483) |
164,169 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
|
2023-03-02 |
4 |
AS |
$22.74 |
$299,823 |
D/D |
(13,184) |
215,220 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
President, Myriad Oncology, |
|
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
29,556 |
135,768 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
|
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
33,665 |
251,446 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
|
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,405 |
254,625 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President, MGL |
|
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
64,686 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
|
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
43,295 |
217,781 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President, MGL |
|
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
44,211 |
106,212 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
See Remarks |
|
2021-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
65,870 |
192,921 |
0 |
- |
|
39 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|